7. Prescribing Cancer Therapies: Guidelines and Workflow for the Advanced Practitioner

Only available as part of a package

Outline:

  • Regulatory Requirements for Prescribing Antineoplastic Therapy
  • Investigational Therapy Prescribing
  • Basic Principles of Safety for Prescribing Antineoplastic Agents
  • Assessment Prior to Prescribing a New Regimen
  • Assessment Prior to Subsequent Cycles or Doses

After completing this educational activity, participants should be able to:

  • Describe national, state, and institutional regulatory guidelines for prescribing antineoplastic agents
  • Identify available resources to guide safe prescribing practices for standard therapies or investigational agents
  • Apply key elements of a comprehensive process for patient assessment prior to prescribing antineoplastic therapies that is tailored to the individual patient
  • Analyze individual practices for gaps in workflow or resources to facilitate practice improvement for expanded role of the AP in prescribing antineoplastic agents

Sandra Kurtin

PhD, ANP-BC, AOCN®, FAPO

The University of Arizona Cancer Center

Sandra Kurtin, PhD, ANP-C, AOCN®, FAPO, is a Nurse Practitioner, Clinical Assistant Professor of Medicine, and Adjunct Clinical Assistant Professor of Nursing at the University of Arizona Cancer Center in Tucson. She has 38 years of oncology experience and maintains a busy clinical practice, with expertise in hematologic malignancies, clinical trials, symptom management, supportive care, caregiver support, and health informatics. Dr. Kurtin is a founding board member of APSHO and an active member of the American Society of Hematology, the American Society of Clinical Oncology, and the Oncology Nursing Society. Dr. Kurtin serves on a number of patient advocacy boards, professional working groups, and editorial boards for peer-reviewed publications relevant to oncology and supportive care. She is widely published in peer-reviewed journals and lectures nationally and internationally.
Dr. Kurtin has the following relevant financial relationships to disclose:
  • Consultant: AstraZeneca, Bristol Myers Squibb, Epizyme, Incyte, Pharmacyclics, Takeda

Key:

Complete
Failed
Available
Locked
Regulatory Requirements for Prescribing Antineoplastic Therapy (17 min.)
Open to view video.
Open to view video.
You must register to access.
Regulatory Requirements for Prescribing Antineoplastic Therapy - Knowledge Check
1 Question  |  Unlimited attempts  |  0/1 points to pass
1 Question  |  Unlimited attempts  |  0/1 points to pass Knowledge Check grades DO NOT COUNT towards earning your CE certificate. You will be informed that you passed this quiz once it has been completed.
You must register to access.
Basic Principles of Safety for Prescribing Antineoplastic Agents (11 min.)
Open to view video.
Open to view video.
You must register to access.
Basic Principles of Safety for Prescribing Antineoplastic Agents - Knowledge Check
1 Question  |  Unlimited attempts  |  0/1 points to pass
1 Question  |  Unlimited attempts  |  0/1 points to pass Knowledge Check grades DO NOT COUNT towards earning your CE certificate. You will be informed that you passed this quiz once it has been completed.
You must register to access.
Assessment Prior to Prescribing a New Regimen (28 min.)
Open to view video.
Open to view video.
You must register to access.
Assessment Prior to Prescribing a New Regimen - Knowledge Check
1 Question  |  Unlimited attempts  |  0/1 points to pass
1 Question  |  Unlimited attempts  |  0/1 points to pass Knowledge Check grades DO NOT COUNT towards earning your CE certificate. You will be informed that you passed this quiz once it has been completed.
You must register to access.
Assessment Prior to Subsequent Cycles or Doses (8 min.)
Open to view video.
Open to view video.
You must register to access.
Assessment Prior to Subsequent Cycles or Doses - Knowledge Check
1 Question  |  Unlimited attempts  |  0/1 points to pass
1 Question  |  Unlimited attempts  |  0/1 points to pass Knowledge Check grades DO NOT COUNT towards earning your CE certificate. You will be informed that you passed this quiz once it has been completed.
You must register to access.
Clinical Pearls and Case Study (5 min.)
Open to view video.
Open to view video.
You must register to access.
Prescribing Cancer Therapies: Guidelines and Workflow for the Advanced Practitioner - Post Test
6 Questions  |  3 attempts  |  5/6 points to pass
6 Questions  |  3 attempts  |  5/6 points to pass This Post Test counts towards your CE Certificate. You must answer at least 5 of 6 questions correctly to earn credit for this module. You have 3 attempts to pass the Post Test.
You must register to access.